Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.72EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.72EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.72ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.72ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.20EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.20ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.20ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.20EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.20EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BU.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BU.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BU.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BU.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EW.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EW.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EW.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EW.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EW.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EW.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EW.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EW.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.18EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.18ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.18ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.18EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.18EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used